# MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

> **NCT04533464** · PHASE2 · RECRUITING · sponsor: **Healios K.K.** · enrollment: 156 (estimated)

## Conditions studied

- Trauma
- Adult Stem Cells

## Interventions

- **BIOLOGICAL:** MultiStem
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04533464
- **Lead sponsor:** Healios K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-09
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2024-05-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04533464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04533464, "MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04533464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*